Topamax Related Published Studies
Well-designed clinical trials related to Topamax (Topiramate)
A Randomized, Double-Blind, Placebo-Controlled Study of Topiramate in the Treatment of Tourette Syndrome. [2009.09.01]
Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures. [2009.09]
A multicenter, outpatient, open-label study to evaluate the dosing, effectiveness, and safety of topiramate as monotherapy in the treatment of epilepsy in clinical practice. [2009.08]
A randomized, double-blind, placebo-controlled trial to assess the efficacy of topiramate in the treatment of post-traumatic stress disorder. [2009.05.29]
Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs. [2009.03]
Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age. [2009.03]
Topiramate add-on treatment in schizophrenia: a randomised, double-blind, placebo-controlled clinical trial. [2009.03]
Bioequivalence of single 100-mg doses of two oral formulations of topiramate: an open-label, randomized-sequence, two-period crossover study in healthy adult male Mexican volunteers. [2009.02]
A double-blind randomized controlled trial of topiramate and amitriptyline either alone or in combination for the prevention of migraine. [2008.12]
Comparison of the effectiveness of topiramate and sodium valproate in pediatric migraine. [2008.12]
Comparing topiramate with naltrexone in the treatment of alcohol dependence. [2008.12]
A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis. [2008.11]
Effects of topiramate and levetiracetam vs placebo on habituation of contingent negative variation in migraine patients. [2008.09.12]
A double-blind randomized controlled trial of topiramate and amitriptyline either alone or in combination for the prevention of migraine. [2008.07.10]
Topiramate in older patients with partial-onset seizures: a pilot double-blind, dose-comparison study. [2008.07]
Using topiramate or naltrexone for the treatment of alcohol-dependent patients. [2008.07]
Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial. [2008.06.09]
Craving decrease with topiramate in outpatient treatment for cocaine dependence: an open label trial. [2008.06]
Attention changes in epilepsy patients following 3-month topiramate or valproate treatment revealed by event-related potential. [2008.06]
An open randomized trial comparing disulfiram and topiramate in the treatment of alcohol dependence. [2008.06]
Effectiveness of topiramate for tobacco dependence in patients with depression; a randomised, controlled trial. [2008.05.07]
Craving decrease with topiramate in outpatient treatment for cocaine dependence: an open label trial. [2008.04.28]
Preliminary evidence for gender-specific effects of topiramate as a potential aid to smoking cessation. [2008.04]
Analysis of safety and tolerability data obtained from over 1,500 patients receiving topiramate for migraine prevention in controlled trials. [2008.03]
Effects of topiramate on urge to drink and the subjective effects of alcohol: a preliminary laboratory study. [2008.03]
Topiramate in essential tremor: findings from double-blind, placebo-controlled, crossover trials. [2008.03]
Treatment of aggression with topiramate in male borderline patients, part II: 18-month follow-up. [2008.03]
Relative influences of adjunctive topiramate and adjunctive lamotrigine on scanning and the effective field of view. [2008.02]
Subcutaneous histamine versus topiramate in migraine prophylaxis: a double-blind study. [2008]
A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic combat-related posttraumatic stress disorder. [2007.12]
Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial. [2007.12]
The impact of topiramate on health-related quality of life indicators in chronic migraine. [2007.11]
Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. [2007.11]
Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy. [2007.11]
Topiramate for treating alcohol dependence: a randomized controlled trial. [2007.10.10]
The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials. [2007.10.04]
Influence of topiramate on olanzapine-related weight gain in women: an 18-month follow-up observation. [2007.10]
Effects of levetiracetam vs topiramate and placebo on visually evoked phase synchronization changes of alpha rhythm in migraine. [2007.10]
Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive-behavior therapy in binge-eating disorder. [2007.09]
The effects on cognitive function and behavioral problems of topiramate compared to carbamazepine as monotherapy for children with benign rolandic epilepsy. [2007.09]
A placebo-controlled, random-assignment, parallel-group pilot study of adjunctive topiramate for patients with schizoaffective disorder, bipolar type. [2007.09]
Time course of adverse events most commonly associated with topiramate for migraine prevention. [2007.08]
Lack of Pharmacokinetic Interaction of Levetiracetam on Carbamazepine, Valproic Acid, Topiramate, and Lamotrigine in Children with Epilepsy. [2007.07.25]
Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. [2007.07]
Weight loss and metabolic effects of topiramate in overweight and obese type 2 diabetic patients: randomized double-blind placebo-controlled trial. [2007.07]
Topiramate in the prophylaxis of pediatric migraine: a double-blind placebo-controlled trial. [2007.07]
Analysis of pooled data from two pivotal controlled trials on the efficacy of topiramate in the prevention of migraine. [2007.07]
Topiramate or valproate in patients with juvenile myoclonic epilepsy: A randomized open-label comparison. [2007.06]
Topiramate monotherapy in newly diagnosed epilepsy in children and adolescents. [2007.06]
A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders. [2007.06]
A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of topiramate controlled release in the treatment of obese type 2 diabetic patients. [2007.06]
Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study. [2007.05.01]
Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. [2007.04.18]
Kinetic and cardiovascular effects of acute topiramate dosing among non-treatment-seeking, methamphetamine-dependent individuals. [2007.03.30]
The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. [2007.03.24]
The effect of topiramate on energy balance in obese men: a 6-month double-blind randomized placebo-controlled study with a 6-month open-label extension. [2007.02]
Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study. [2007.02]
Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. [2007.02]
Weight loss and metabolic effects of topiramate in overweight and obese type 2 diabetic patients: randomized double-blind placebo-controlled trial. [2007.01.30]
Topiramate for the Treatment of Binge Eating Disorder Associated With Obesity: A Placebo-Controlled Study. [2007.01.26]
Efficacy and safety of topiramate in combination with metformin in the treatment of obese subjects with type 2 diabetes: a randomized, double-blind, placebo-controlled study. [2007.01]
Topiramate in patients with episodic migraine: reducing the risk for chronic forms of headache. [2007.01]
Truncated AUCs in the assessment of the bioequivalence of topiramate, a long half-life drug. [2007]
Topiramate reduces the harm of excessive drinking: implications for public health and primary care. [2006.11]
Adjunctive topiramate therapy in patients receiving a mood stabilizer for bipolar I disorder: a randomized, placebo-controlled trial. [2006.11]
Topiramate for migraine prevention in adolescents: a pooled analysis of efficacy and safety. [2006.11]
Assessing the ability of topiramate to improve the daily activities of patients with migraine. [2006.10]
A prospective, open-label, long-term study of the efficacy and tolerability of topiramate in the prophylaxis of chronic tension-type headache. [2006.10]
Topiramate in the treatment of trichotillomania: an open-label pilot study. [2006.09]
Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy. [2006.08.08]
Efficacy and tolerability of topiramate 200 mg/d in the prevention of migraine with/without aura in adults: a randomized, placebo-controlled, double-blind, 12-week pilot study. [2006.07]
Topiramate in treatment of patients with chronic low back pain: a randomized, double-blind, placebo-controlled study. [2006.07]
The impact of migraine on daily activities: effect of topiramate compared with placebo. [2006.06]
Efficacy and safety of topiramate in combination with metformin in the treatment of obese subjects with type 2 diabetes: a randomized, double-blind, placebo-controlled study. [2006.05.16]
Distinct cognitive neurophysiologic profiles for lamotrigine and topiramate. [2006.04]
Comparison of the effect of topiramate and sodium valporate in migraine prevention: a randomized blinded crossover study. [2006.04]
Topiramate in essential tremor: a double-blind, placebo-controlled trial. [2006.03.14]
Topiramate for migraine prevention. [2006.03]
Effects of topiramate in combination with intravenous nicotine in overnight abstinent smokers. [2006.03]
Topiramate in essential tremor. [2006.01.25]
Topiramate treatment in bulimia nervosa patients: a randomized, double-blind, placebo-controlled trial. [2005.12]
Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial. [2005.11]
Topiramate in patients with juvenile myoclonic epilepsy. [2005.11]
A randomized, double-blind, placebo-controlled trial of topiramate in adults with epilepsy and intellectual disability: impact on seizures, severity, and quality of life. [2005.11]
Randomized dose-controlled study of topiramate as first-line therapy in epilepsy. [2005.10]
Topiramate improves health-related quality of life when used to prevent migraine. [2005.09]
Topiramate for phantom limb pain: a time-series analysis. [2005.09]
Topiramate add-on in treatment-resistant schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial. [2005.08]
Topiramate in treatment of depressive and anger symptoms in female depressive patients: a randomized, double-blind, placebo-controlled study. [2005.08]
Use of oral topiramate to promote smoking abstinence among alcohol-dependent smokers: a randomized controlled trial. [2005.07.25]
Efficacy and safety of topiramate in the treatment of obese subjects with essential hypertension. [2005.07.15]
Topiramate as an adjuvant treatment with atypical antipsychotics in schizophrenic patients experiencing weight gain. [2005.07]
Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers. [2005.06.28]
Influence of topiramate on olanzapine-related adiposity in women: a random, double-blind, placebo-controlled study. [2005.06]
Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy. [2005.05]
Treatment of aggression with topiramate in male borderline patients: a double-blind, placebo-controlled study. [2005.03.01]
Topiramate monotherapy in epilepsy and migraine prevention. [2005.02]
Plasma and whole blood pharmacokinetics of topiramate: the role of carbonic anhydrase. [2005.02]
Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study. [2005.01]
Topiramate and divalproex in combination with risperidone for acute mania: a randomized open-label study. [2005.01]
Topiramate in migraine prophylaxis: a randomised double-blind versus placebo study. [2004.12]
|
